Our Pricing

Buy Mounjaro Injection Online - UK Prescription Service

Published on: June 03, 2026

If you're looking to buy Mounjaro injection online UK through a registered pharmacy, Cured Pharmacy offers genuine tirzepatide KwikPens from £135.00 with transparent pricing, free clinical consultation by UK prescribers, and discreet next-day delivery. Every Mounjaro prescription requires a clinical assessment to ensure the treatment is safe and suitable for your individual circumstances.

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the SURMOUNT-1 clinical trial, participants receiving the 15mg maintenance dose of tirzepatide achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% in the placebo group [1]. This dual-action mechanism helps reduce hunger signals, slow gastric emptying, and improve glycaemic control, making tirzepatide one of the most effective pharmacological interventions for obesity currently available in the UK.

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. Treatment typically begins at 2.5mg weekly for four weeks, then increases gradually to minimise gastrointestinal side effects, with maintenance doses ranging from 5mg to 15mg depending on individual response and tolerability [2].

Mounjaro Pricing and What's Included at Cured Pharmacy

At Cured Pharmacy, Mounjaro injections start from £124.99 with transparent upfront pricing displayed before you begin your consultation. This includes your medication, free clinical assessment by a UK-registered prescriber, and discreet delivery to your door. There are no hidden consultation fees or subscription charges—you only pay for the medication you're prescribed.

Your prescription will be reviewed by our clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), ensuring every treatment decision meets UK pharmaceutical standards. We guarantee 100% genuine UK-licensed medicines sourced through regulated channels, never grey-market imports or unlicensed alternatives.

Why Transparent Pricing Matters

Many online services advertise low starting prices but add consultation fees, delivery charges, or mandatory subscription plans at checkout. At Cured Pharmacy, the price you see is the price you pay, allowing you to make informed decisions about your weight management journey without unexpected costs.

Mounjaro vs Wegovy: Comparing GLP-1 Weight Loss Treatments

Both Mounjaro and Wegovy are injectable medications licensed in the UK for chronic weight management, but they work through different mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that activates a single hormonal pathway, while Mounjaro's tirzepatide activates both GIP and GLP-1 receptors for dual-pathway action [3].

Head-to-head trials suggest tirzepatide may produce greater average weight loss than semaglutide, though individual responses vary considerably [4]. Wegovy is administered as a once-weekly injection starting at 0.25mg and titrating up to a maintenance dose of 2.4mg, while Mounjaro follows a similar weekly schedule with maintenance doses up to 15mg.

Your UK prescriber will assess your medical history, current medications, weight loss goals, and any contraindications to determine which treatment is most appropriate. Some patients may be better suited to semaglutide-based options, while others may benefit more from tirzepatide's dual-action mechanism.

Other Weight Loss Options Available

Beyond injectable GLP-1 treatments, Cured Pharmacy also offers Saxenda (liraglutide), a daily injection option, and oral medications like Orlistat and Xenical for patients who prefer tablet-based treatments. Your prescriber will discuss all suitable options during your consultation.

How to Buy Mounjaro Injection Online UK: The Consultation Process

Purchasing Mounjaro online through Cured Pharmacy involves a straightforward three-step process that meets all UK regulatory requirements. First, you complete a free online medical questionnaire that takes under three minutes, covering your weight history, current health conditions, medications, and weight loss goals.

Next, a UK-registered prescriber reviews your assessment, usually within 24 hours on working days. They'll evaluate whether Mounjaro is clinically appropriate and safe for you, considering factors like your BMI, existing medical conditions, and any contraindications. If approved, your prescription is sent electronically to our dispensing team.

Finally, our GPhC-registered pharmacy dispenses your medication and arranges discreet next-day delivery in plain, unmarked packaging. You'll receive full instructions on injection technique, dose escalation schedule, and how to store your Mounjaro pens safely. Our clinical team remains available throughout your treatment for any questions or concerns.

Expected Results and Clinical Evidence for Mounjaro

Clinical trial data from the SURMOUNT programme demonstrates that tirzepatide can support significant weight reduction when combined with a reduced-calorie diet and increased physical activity [1]. In SURMOUNT-1, 91% of participants on the 15mg dose achieved at least 5% body weight loss, and 57% achieved at least 20% weight loss over 72 weeks [1].

Individual results vary considerably based on starting weight, adherence to lifestyle modifications, dose prescribed, and metabolic factors. Most patients begin noticing appetite reduction within the first few weeks of treatment, with measurable weight loss typically becoming apparent after 4-8 weeks [5].

It's important to understand that Mounjaro is not a standalone solution—it works most effectively as part of a comprehensive weight management programme including dietary changes, regular physical activity, and behavioural modifications. Your prescriber may recommend working with a dietitian or weight management service alongside medication.

Long-Term Considerations

Weight management is typically a long-term commitment, and many patients continue treatment for 12 months or longer to achieve and maintain their goals. Your prescriber will schedule regular reviews to monitor your progress, adjust dosing if needed, and assess whether continued treatment remains appropriate.

Mounjaro Side Effects and Safety Information

The most commonly reported side effects of Mounjaro are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [2]. These effects are usually mild to moderate and tend to decrease over time as your body adjusts to the medication. Starting at a low dose and titrating gradually helps minimise these symptoms.

More serious but rare side effects include pancreatitis, gallbladder problems, kidney injury (usually related to dehydration from vomiting or diarrhoea), and allergic reactions. Mounjaro carries a boxed warning in some jurisdictions regarding thyroid C-cell tumours observed in animal studies, though relevance to humans remains unclear [2]. It should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Mounjaro is contraindicated in pregnancy and breastfeeding. Women of childbearing potential should use effective contraception during treatment and discontinue Mounjaro at least two months before a planned pregnancy. Your prescriber will review your complete medical history to identify any contraindications before prescribing.

If you experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or allergic reactions, stop using Mounjaro and seek immediate medical attention. Always inform your prescriber about any side effects you experience during treatment.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14269 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to lifestyle modifications.